About
CardioRenal is a French company developing a digital therapeutics solution for chronic kidney disease (CKD) management. Their non-invasive medical device, TENOR, allows patients to measure their blood potassium levels at home, providing real-time data to physicians to optimize treatment and prevent cardiac complications. The company aims to improve home-based care for patients with severe chronic kidney and heart failure.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Cardio Renal do?
CardioRenal is a French company developing a digital therapeutics solution for chronic kidney disease (CKD) management. Their non-invasive medical device, TENOR, allows patients to measure their blood potassium levels at home, providing real-time data to physicians to optimize treatment and prevent cardiac complications. The company aims to improve home-based care for patients with severe chronic kidney and heart failure.
How much funding has Cardio Renal raised?
Cardio Renal has raised a total of $4M in funding. The most recent round on record is Seed.
When was Cardio Renal founded?
Cardio Renal was founded in 2013.